Authors: NORBERG T LENNERSTRAND J INGANAS M BERGH J

Citation: T. Norberg et al., COMPARISON BETWEEN P53 PROTEIN MEASUREMENTS USING THE LUMINOMETRIC IMMUNOASSAY AND IMMUNOHISTOCHEMISTRY WITH DETECTION OF P53 GENE-MUTATIONS USING CDNA SEQUENCING IN HUMAN BREAST-TUMORS, International journal of cancer, 79(4), 1998, pp. 376-383

Authors: LENNERSTRAND J RYTTING AS VRANG L GRONOWITZ JS KALLANDER CFR

Citation: J. Lennerstrand et al., APPLICATION OF A CHAIN TERMINATION ASSAY FOR CHARACTERIZATION OF REVERSE-TRANSCRIPTASE FROM AZT-RESISTANT HIV ISOLATES, Antiviral chemistry & chemotherapy, 7(6), 1996, pp. 313-320

Authors: DEWITTE HH FOEKENS JA LENNERSTRAND J SMID M LOOK MP KLIJN JGM BENRAAD TJ BERNS EMJJ

Citation: Hh. Dewitte et al., PROGNOSTIC-SIGNIFICANCE OF TP53 ACCUMULATION IN HUMAN PRIMARY BREAST-CANCER - COMPARISON BETWEEN A RAPID QUANTITATIVE IMMUNOASSAY AND SSCP ANALYSIS, International journal of cancer, 69(2), 1996, pp. 125-130

Authors: LENNERSTRAND J RYTTING AS ORVELL C GRONOWITZ JS KALLANDER CFR

Citation: J. Lennerstrand et al., A METHOD FOR COMBINED IMMUNOAFFINITY PURIFICATION AND ASSAY OF HIV-1 REVERSE-TRANSCRIPTASE ACTIVITY USEFUL FOR CRUDE SAMPLES, Analytical biochemistry, 235(2), 1996, pp. 141-152

Authors: BORG A LENNERSTRAND J STENMARKASKMALM M FERNO M BRISFORS A OHRVIK A STAL O KILLANDER D LANE D BRUNDELL J

Citation: A. Borg et al., PROGNOSTIC-SIGNIFICANCE OF P53 OVEREXPRESSION IN PRIMARY BREAST-CANCER - A NOVEL LUMINOMETRIC IMMUNOASSAY APPLICABLE ON STEROID-RECEPTOR CYTOSOLS, British Journal of Cancer, 71(5), 1995, pp. 1013-1017

Authors: NEUMULLER M KARLSSON A LENNERSTRAND J KALLANDER CFR SANDSTROM E HOLMBERG V GRONOWITZ JS

Citation: M. Neumuller et al., HIV-1 REVERSE-TRANSCRIPTASE INHIBITING ANTIBODY TITER IN SERUM - RELATION TO DISEASE PROGRESSION AND TO CORE-ANTIBODY LEVELS, Journal of medical virology, 36(4), 1992, pp. 283-291